Back to top

Myriad Genetics Inc: (BATS: MYGN)

(U.S: BATS) As of Jul 29, 2014 09:53 AM ET

 Add to portfolio

 ZacksTrade Now

$36.37 USD

36.37

+0.26 (0.72%)

Volume: 4,660

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Industry / Sector Report

Industry: MED-BIOMED/GENE

Zacks Industry Rank: 101 / 265 (Top 38.11%)

Rank in Industry:

Premium Research: Industry Analysis

Top Peers Symbol Zacks Rank
MYRIAD GENETICS MYGN
ACTELION LTD ALIOF
CURIS INC CRIS
ILLUMINA INC ILMN
ONCOLYTICS BIO ONCY
SEATTLE GENETIC SGEN
AASTROM BIOSCI ASTM
AEGERION PHARMA AEGR
ALEXION PHARMA ALXN
AMICUS THERAPT FOLD

Recommendations and Estimates

Company Industry SP500
Average Recommendation (1=Buy, 5=Sell) 2.71 1.47 9.99
Current Quarter Estimate 0.46 3.81 -999.00
Year Ago Quarter Estimate 0.53 1.95 26.36
Next Quarter Estimate 0.48 3.91 -999.00
Next Year Estimate 2.06 1.62 26.92

Growth Rates

Company Industry SP500
This Year (NA) NA 12.90 9.00
Next Year (8.1) 8.10 5.90 6.80
Last 5 Years NA 19.00 11.20
Next 5 Years 14.90 18.40 NA

Financials

Company Industry
Price/Earnings (TTM) 14.62 3.75
Price/Book (MRQ) 3.65 4.46
Price/Cash Flow (MRFY) 18.44 25.96
Dividend Yield 0.00% 0.00%
Net Profit Margin (TTM) 24.45% -0.16%
Return on Equity (TTM) 27.78% -18.60%
Debt to Equity (MRQ) NA 0.11

MRQ = Most Recent Quarter

TTM = Trailing Twelve Months

MRFY = Most Recent Fiscal Year

Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.